229 related articles for article (PubMed ID: 7772402)
1. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells].
Akiyama Y; Yamasaki T; Fukuda M; Moritake K
No To Shinkei; 1995 Apr; 47(4):349-55. PubMed ID: 7772402
[TBL] [Abstract][Full Text] [Related]
2. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
Ohyama K
Nihon Geka Hokan; 1993 Mar; 62(2):92-115. PubMed ID: 8239865
[TBL] [Abstract][Full Text] [Related]
3. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
5. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
6. Taxol provides a second signal for murine macrophage tumoricidal activity.
Manthey CL; Perera PY; Salkowski CA; Vogel SN
J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
Jun CD; Yoon HJ; Kim HM; Chung HT
Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
[TBL] [Abstract][Full Text] [Related]
8. Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages.
Kirikae T; Ojima I; Ma Z; Kirikae F; Hirai Y; Nakano M
Biochem Biophys Res Commun; 1998 Apr; 245(3):698-704. PubMed ID: 9588177
[TBL] [Abstract][Full Text] [Related]
9. An improved experimental model for the study of in vitro release of nitric oxide by murine peritoneal macrophages.
Marcinkiewicz J; Pater M; Grabowska A
Arch Immunol Ther Exp (Warsz); 1994; 42(2):95-9. PubMed ID: 7503653
[TBL] [Abstract][Full Text] [Related]
10. In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing.
Son K; Kim YM
Cancer Res; 1995 Dec; 55(23):5524-7. PubMed ID: 7585626
[TBL] [Abstract][Full Text] [Related]
11. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.
Hatzigeorgiou DE; He S; Sobel J; Grabstein KH; Hafner A; Ho JL
J Immunol; 1993 Oct; 151(7):3682-92. PubMed ID: 8397259
[TBL] [Abstract][Full Text] [Related]
12. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM
Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophages.
Kirikae T; Ojima I; Kirikae F; Ma Z; Kuduk SD; Slater JC; Takeuchi CS; Bounaud PY; Nakano M
Biochem Biophys Res Commun; 1996 Oct; 227(1):227-35. PubMed ID: 8858130
[TBL] [Abstract][Full Text] [Related]
14. Alteration of macrophage cytotoxicity through endogenous interferon and tumor necrosis factor alpha induction by propanil.
Theus SA; Tabor DR; Gandy J; Barnett JB
Toxicol Appl Pharmacol; 1993 Jan; 118(1):46-52. PubMed ID: 7679225
[TBL] [Abstract][Full Text] [Related]
15. IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma.
Kichian K; Nestel FP; Kim D; Ponka P; Lapp WS
J Immunol; 1996 Oct; 157(7):2851-6. PubMed ID: 8816389
[TBL] [Abstract][Full Text] [Related]
16. Effect of L-arginine on the retention of macrophage tumoricidal activity.
Takema M; Inaba K; Uno K; Kakihara K; Tawara K; Muramatsu S
J Immunol; 1991 Mar; 146(6):1928-33. PubMed ID: 2005387
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
18. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene.
Gao JJ; Filla MB; Fultz MJ; Vogel SN; Russell SW; Murphy WJ
J Immunol; 1998 Nov; 161(9):4803-10. PubMed ID: 9794412
[TBL] [Abstract][Full Text] [Related]
19. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.
Klostergaard J; Leroux ME; Hung MC
J Immunol; 1991 Oct; 147(8):2802-8. PubMed ID: 1918993
[TBL] [Abstract][Full Text] [Related]
20. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
